Addiction-related genes in gambling disorders: New insights from parallel human and pre-clinical models

Molecular Psychiatry

Volumn 20, Issue 8, 2015, Pages 1002-1010

  Lobo, D S S ^a,b   Aleksandrova, L ^a,b   Knight, J ^a,b   Casey, D M ^c   El Guebaly, N ^d   Nobrega, J N ^a,b   Kennedy, J L ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c Mental Health Commission of Canada 2008e2011   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 3 RECEPTOR; MESSENGER RNA; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CAMK2D PROTEIN, HUMAN; DRD3 PROTEIN, HUMAN; DRD3 PROTEIN, RAT;

ADDICTION; AGE DISTRIBUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASIC RESEARCH; BRAIN REGION; CAMK2D GENE; CONTROLLED STUDY; DRD3 GENE; DSM-IV; EMBRYONIC STEM CELL; GAMBLING; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HERITABILITY; HUMAN; HUMAN GENETICS; IN SITU HYBRIDIZATION; MALE; NEUROBIOLOGY; NONHUMAN; OLFACTORY NERVOUS SYSTEM; PATHOLOGICAL GAMBLING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RAT; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; ADULT; ANIMAL; BRAIN; DISEASE MODEL; FEMALE; GAME; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; METABOLISM; RISK; SPRAGUE DAWLEY RAT;

ADULT; ANIMALS; BEHAVIOR, ADDICTIVE; BRAIN; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; DISEASE MODELS, ANIMAL; FEMALE; GAMBLING; GAMES, EXPERIMENTAL; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D3; RISK; RNA, MESSENGER;

EID: 84937815255     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2014.113     Document Type: Article

References (83)

1. Williams R, Rehm J, Stevens R. The Social and Economic Impacts of Gambling: Final Report: Canadian Consortium for Gambling Research; 2011. 3 November 2011.
2. Kessler RC, Hwang I, LaBrie R, Petukhova M, Sampson NA, Winters KC et al. DSM-IV pathological gambling in the National Comorbidity Survey Replication. Psychol Med 2008; 38: 1351-1360.
3. Currie SR, Hodgins DC, Casey DM, el-Guebaly N, Smith GJ, Williams RJ et al. Examining the predictive validity of low-risk gambling limits with longitudinal data. Addiction 2012; 107: 400-406.
4. Currie SR, Hodgins DC, Wang J, el-Guebaly N, Wynne H, Miller NV. Replication of low-risk gambling limits using canadian provincial gambling prevalence data. J Gambl Stud 2008; 24: 321-335.
5. Shaffer HJ, Martin R. Disordered gambling: etiology, trajectory, and clinical considerations. Annu Rev Clin Psychol 2011; 7: 483-510.
6. Petry NM. Pathological gambling and the DSM-5. Int Gambl Stud 2010; 10: 113-115.
7. Leeman RF, Potenza MN. Similarities and differences between pathological gambling and substance use disorders: a focus on impulsivity and compulsivity. Psychopharmacology (Berl) 2011; 219: 469-490.
8. Goudriaan AE, Oosterlaan J, de Beurs E, van den Brink W. Psychophysiological determinants and concomitants of deficient decision making in pathological gamblers. Drug Alcohol Depend 2006; 84: 231-239.
9. Lawrence AJ, Luty J, Bogdan NA, Sahakian BJ, Clark L. Problem gamblers share deficits in impulsive decision-making with alcohol-dependent individuals. Addiction 2009; 104: 1006-1015.
10. Petry NM. Substance abuse, pathological gambling, and impulsiveness. Drug Alcohol Depend 2001; 63: 29-38.
11. Bechara A, Damasio AR, Damasio H, Anderson SW. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 1994; 50: 7-15.
12. Slutske WS, Eisen S, True WR, Lyons MJ, Goldberg J, Tsuang M. Common genetic vulnerability for pathological gambling and alcohol dependence in men. Arch Gen Psychiatry2000; 57: 666-673.
13. Eisen SA, Slutske WS, Lyons MJ, Lassman J, Xian H, Toomey R et al. The genetics of pathological gambling. Semin Clin Neuropsychiatry 2001; 6: 195-204.
14. Slutske WS, Zhu G, Meier MH, Martin NG. Genetic and environmental influences on disordered gambling in men and women. Arch Gen Psychiatry 2010; 67: 624-630.
15. Lobo DS, Kennedy JL. Genetic aspects of pathological gambling: a complex disorder with shared genetic vulnerabilities. Addiction 2009; 104: 1454-1465.
16. Lim S, Ha J, Choi SW, Kang SG, Shin YC. Association study on pathological gambling and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in a Korean population. J Gambl Stud 2012; 28: 481-491.
17. Lind PA, Zhu G, Montgomery GW, Madden PA, Heath AC, Martin NG et al. Genome-wide association study of a quantitative disordered gambling trait. Addict Biol 2012; 18: 511-522.
18. Li CY, Zhou WZ, Zhang PW, Johnson C, Wei L, Uhl GR. Meta-analysis and genomewide interpretation of genetic susceptibility to drug addiction. BMC Genomics 2011; 12: 508.
19. Potenza MN. The importance of animal models of decision making, gambling, and related behaviors: implications for translational research in addiction. Neuropsychopharmacology 2009; 34: 2623-2624.
20. Winstanley CA, Cocker PJ, Rogers RD. Dopamine modulates reward expectancy during performance of a slot machine task in rats: evidence for a 'near-miss' effect. Neuropsychopharmacology 2011; 36: 913-925.
21. Zeeb FD, Robbins TW, Winstanley CA. Serotonergic and dopaminergic modulation of gambling behavior as assessed using a novel rat gambling task. Neuropsychopharmacology 2009; 34: 2329-2343.
22. Winstanley CA. The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders. Br J Pharmacol 2011; 164: 1301-1321.
23. el-Guebaly N, Casey DM, Hodgins DC, Smith GJ, Williams RJ, Schopflocher DP et al. Designing a longitudinal cohort study of gambling in Alberta: rationale, methods, and challenges. J Gambl Stud. 2008; 24: 479-504.
24. NORC. National Opinion Research Center. Gambling Impact and Behavior Study, Report to the National Gambling Impact Study Commission; 1999 Contract No.: Document Number.
25. Li C, Mao X, Wei L. Genes and (common) pathways underlying drug addiction. PLoS Comput Biol 2008; 4: e2.
26. Busto A, Souza RP, Lobo DS, Shaikh SA, Zawertailo LA, Busto UE et al. Cocaine and amphetamine regulated transcript (CART) gene in the comorbidity of schizophrenia with alcohol use disorders and nicotine dependence. Prog Neuropsychopharmacol Biol Psychiatry. 2010; 34: 834-836.
27. Lobo DS, Souza RP, Tong RP, Casey DM, Hodgins DC, Smith GJ et al. Association of functional variants in the dopamine D2-like receptors with risk for gambling behaviour in healthy Caucasian subjects. Biol Psychol 2010; 85: 33-37.
28. Sabbatini da Silva Lobo D, Vallada HP, Knight J, Martins SS, Tavares H, Gentil V et al. Dopamine genes and pathological gambling in discordant sib-pairs. J Gambl Stud 2007; 23: 421-433.
29. Wilson D, da Silva Lobo DS, Tavares H, Gentil V, Vallada H. Family-based association analysis of serotonin genes in pathological gambling disorder: evidence of vulnerability risk in the 5HT-2A receptor gene. J Mol Neurosci 2012; 49: 550-553.
30. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
31. Gauderman W, Morrison J. QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies. http://hydra.usc.edu/gxe.
32. Smith GJ, Wynne HJ. Measuring Gambling and Problem Gambling in Alberta using the Canadian Problem Gambling Index. Alberta Gaming Research Institute: Edmonton, AB, 2002 Contract No.: Document Number.
33. Wiebe J, Mun P, Kauffman N. Gambling and Problem Gambling in Ontario 2005. Responsible Gambling Council: Toronto, ON, 2005 Contract No.: Document Number|.
34. Nyholt DR. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004; 74: 765-769.
35. Aleksandrova LR, Creed MC, Fletcher PJ, Lobo DS, Hamani C, Nobrega JN. Deep brain stimulation of the subthalamic nucleus increases premature responding in a rat gambling task. Behav Brain Res 2013; 245C: 76-82.
36. Currie SR, Miller NV, Hodgins DC, Wang J. Defining a threshold of harmfrom gambling for population health surveillance research. Int Gambl Stud 2008; 9: 19-38.
37. Pirinen M, Donnelly P, Spencer CC. Including known covariates can reduce power to detect genetic effects in case-control studies. Nat Genet 2012; 44: 848-851.
38. Colantuoni C, Lipska BK, Ye T, Hyde TM, Tao R, Leek JT et al. Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature 2011; 478: 519-523.
39. Boyle AP, Hong EL, Hariharan M, Cheng Y, Schaub MA, Kasowski M et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res 2012; 22: 1790-1797.
40. Stelzer G, Inger A, Olender T, Iny-Stein T, Dalah I, Harel A et al. GeneDecks: paralog hunting and gene-set distillation with GeneCards annotation. OMICS 2009; 13: 477-487.
41. Creed MC, Hamani C, Nobrega JN. Early gene mapping after deep brain stimulation in a rat model of tardive dyskinesia: comparison with transient local inactivation. Eur Neuropsychopharmacol 2012; 22: 506-517.
42. Huang W, Payne TJ, Ma JZ, Li MD. A functional polymorphism, rs6280, in DRD3 is significantly associated with nicotine dependence in European-American smokers. Am J Med Genet B Neuropsychiatr Genet 2008; 147B: 1109-1115.
43. Novak G, LeBlanc M, Zai C, Shaikh S, Renou J, DeLuca V et al. Association of polymorphisms in the BDNF, DRD1 and DRD3 genes with tobacco smoking in schizophrenia. Ann Hum Genet 2010; 74: 291-298.
44. Kuo SC, Yeh YW, Chen CY, Huang CC, Chang HA, Yen CH et al. DRD3 variation associates with early-onset heroin dependence, but not specific personality traits. Prog Neuropsychopharmacol Biol Psychiatry 2014; 51: 1-8.
45. Hack LM, Kalsi G, Aliev F, Kuo PH, Prescott CA, Patterson DG et al. Limited associations of dopamine system genes with alcohol dependence and related traits in the Irish Affected Sib Pair Study of Alcohol Dependence (IASPSAD). Alcohol Clin Exp Res 2011; 35: 376-385.
46. Comings DE, Gade-Andavolu R, Gonzalez N, Wu S, Muhleman D, Chen C et al. The additive effect of neurotransmitter genes in pathological gambling. Clin Genet 2001; 60: 107-116.
47. da Silva Lobo DS, Vallada HP, Knight J, Martins SS, Tavares H, Gentil V et al. Dopamine genes and pathological gambling in discordant sib-pairs. J Gambl Stud 2007; 23: 421-433.
48. Gasso P, Mas S, Oliveira C, Bioque M, Parellada E, Bernardo M et al. Searching for functional SNPs or rare variants in exonic regions of DRD3 in risperidone-treated patients. Eur Neuropsychopharmacol 2011; 21: 294-299.
49. Ambermoon P, Carter A, Hall WD, Dissanayaka NN, O'Sullivan JD. Impulse control disorders in patients with Parkinson's disease receiving dopamine replacement therapy: evidence and implications for the addictions field. Addiction 2011; 106: 283-293.
50. Lee JY, Lee EK, Park SS, Lim JY, Kim HJ, Kim JS et al. Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson's disease. Mov Disord 2009; 24: 1803-1810.
51. Ray NJ, Strafella AP. Imaging impulse control disorders in Parkinson's disease and their relationship to addiction. J Neural Transm 2012; 120: 659-664.
52. Boileau I, Payer D, Chugani B, Lobo D, Behzadi A, Rusjan PM et al. The D(2/3) dopamine receptor in pathological gambling: a positron emission tomography study with [(11) C]-(+)-propyl-hexahydro-naphtho-oxazin and [(11) C]raclopride. Addiction 2013; 108: 953-963.
53. Rabiner EA, Slifstein M, Nobrega J, Plisson C, Huiban M, Raymond R et al. In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: studies in non-human primates and transgenic mice. Synapse 2009; 63: 782-793.
54. Cocker PJ, Dinelle K, Kornelson R, Sossi V, Winstanley CA. Irrational choice under uncertainty correlates with lower striatal D2/3 receptor binding in rats. J Neurosci 2012; 32: 15450-15457.
55. Tremblay M, Cocker PJ, Hosking JG, Zeeb FD, Rogers RD, Winstanley CA. Dissociable effects of basolateral amygdala lesions on decision making biases in rats when loss or gain is emphasized. Cogn Affect Behav Neurosci advance online publication, 26 March 2014 (e-pub ahead of print).
56. Zeeb FD, Winstanley CA. Lesions of the basolateral amygdala and orbitofrontal cortex differentially affect acquisition and performance of a rodent gambling task. J Neurosci 2011; 31: 2197-2204.
57. Xu J, Hassanzadeh B, Chu W, Tu Z, Jones LA, Luedtke RR et al. [3H]4-(dimethylamino)-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl) butyl)benzamide: a selective radioligand for dopamine D(3) receptors. II. Quantitative analysis of dopamine D (3) and D(2) receptor density ratio in the caudate-putamen. Synapse 2010; 64: 449-459.
58. Rizzo G, Veronese M, Heckemann RA, Selvaraj S, Howes OD, Hammers A et al. The predictive power of brain mRNA mappings for in vivo protein density: a positron emission tomography correlation study. J Cereb Blood Flow Metab 2014; 34: 827-835.
59. Boileau I, Payer D, Houle S, Behzadi A, Rusjan PM, Tong J et al. Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study. J Neurosci 2012; 32: 1353-1359.
60. Payer DE, Behzadi A, Kish SJ, Houle S, Wilson AA, Rusjan PM et al. Heightened D(3) dopamine receptor levels in cocaine dependence and contributions to the addiction behavioral phenotype: a positron emission tomography study with [(11) C]-(+)-PHNO. Neuropsychopharmacology 2014; 39: 311-318.
61. Buckholtz JW, Treadway MT, Cowan RL, Woodward ND, Li R, Ansari MS et al. Dopaminergic network differences in human impulsivity. Science 2010; 329: 532.
62. Boileau I, Payer D, Chugani B, Lobo DS, Houle S, Wilson AA et al. In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: a positron emission tomography study with [C]-(+)-PHNO. Mol Psychiatry advance online publication, 10 December 2013; doi: 10.1038/mp.2013.163 (e-pub ahead of print).
63. Zack M, Featherstone RE, Mathewson S, Fletcher PJ. Chronic exposure to a gambling-like schedule of reward predictive stimuli can promote sensitization to amphetamine in rats. Front Behav Neurosci 2014; 8: 36.
64. Diaz J, Pilon C, Le Foll B, Gros C, Triller A, Schwartz JC et al. Dopamine D3 receptors expressed by all mesencephalic dopamine neurons. J Neurosci 2000; 20: 8677-8684.
65. Fog JU, Khoshbouei H, Holy M, Owens WA, Vaegter CB, Sen N et al. Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport. Neuron 2006; 51: 417-429.
66. Sakurai S, Yu L, Tan SE. Roles of hippocampal N-methyl-D-aspartate receptors and calcium/calmodulin-dependent protein kinase II in amphetamine-produced conditioned place preference in rats. Behav Pharmacol 2007; 18: 497-506.
67. Licata SC, Schmidt HD, Pierce RC. Suppressing calcium/calmodulin-dependent protein kinase II activity in the ventral tegmental area enhances the acute behavioural response to cocaine but attenuates the initiation of cocaine-induced behavioural sensitization in rats. Eur J Neurosci 2004; 19: 405-414.
68. Jackson KJ, Walters CL, Damaj MI. Beta 2 subunit-containing nicotinic receptors mediate acute nicotine-induced activation of calcium/calmodulin-dependent protein kinase II-dependent pathways in vivo. J Pharmacol Exp Ther 2009; 330: 541-549.
69. Mansvelder HD, McGehee DS. Long-term potentiation of excitatory inputs to brain reward areas by nicotine. Neuron 2000; 27: 349-357.
70. Tang L, Shukla PK, Wang LX, Wang ZJ. Reversal of morphine antinociceptive tolerance and dependence by the acute supraspinal inhibition of Ca(2+)/calmodulin-dependent protein kinase II. J Pharmacol Exp Ther 2006; 317: 901-909.
71. Faison MO, Perozzi EF, Caran N, Stewart JK, Tombes RM. Axonal localization of delta Ca2+/calmodulin-dependent protein kinase II in developing P19 neurons. Int J Dev Neurosci 2002; 20: 585-592.
72. Zhang M, Shan H, Gu Z, Wang D, Wang T, Wang Z et al. Increased expression of calcium/calmodulin-dependent protein kinase type II subunit delta after rat traumatic brain injury. J Mol Neurosci 2012; 46: 631-643.
73. Sharp BM, Chen H, Gong S, Wu X, Liu Z, Hiler K et al. Gene expression in accumbens GABA neurons from inbred rats with different drug-taking behavior. Genes Brain Behav 2011; 10: 778-788.
74. Sawai T, Bernier F, Fukushima T, Hashimoto T, Ogura H, Nishizawa Y. Estrogen induces a rapid increase of calcium-calmodulin-dependent protein kinase II activity in the hippocampus. Brain Res 2002; 950: 308-311.
75. Zhen X, Goswami S, Abdali SA, Frankfurt M, Friedman E. Estrogen-modulated frontal cortical CaMKII activity and behavioral supersensitization induced by prolonged cocaine treatment in female rats. Psychopharmacology (Berl) 2007; 191: 323-331.
76. Konhilas JP, Maass AH, Luckey SW, Stauffer BL, Olson EN, Leinwand LA. Sex modifies exercise and cardiac adaptation in mice. Am J Physiol Heart Circ Physiol 2004; 287: H2768-H2776.
77. Ma Y, Cheng WT, Wu S, Wong TM. Oestrogen confers cardioprotection by suppressing Ca2+/calmodulin-dependent protein kinase II. Br J Pharmacol 2009; 157: 705-715.
78. Comings DE, Gade R, Wu S, Chiu C, Dietz G, Muhleman D et al. Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors. Mol Psychiatry 1997; 2: 44-56.
79. Comings DE, Rosenthal RJ, Lesieur HR, Rugle LJ, Muhleman D, Chiu C et al. A study of the dopamine D2 receptor gene in pathological gambling. Pharmacogenetics 1996; 6: 223-234.
80. Comings DE, Gonzalez N, Wu S, Gade R, Muhleman D, Saucier G et al. Studies of the 48 bp repeat polymorphism of the DRD4 gene in impulsive, compulsive, addictive behaviors: Tourette syndrome, ADHD, pathological gambling, and substance abuse. Am J Med Genet 1999; 88: 358-368.
81. Ibanez A, de Castro IP, Fernandez-Piqueras J, Blanco C, Saiz-Ruiz J. Pathological gambling and DNA polymorphic markers at MAO-A and MAO-B genes. Mol Psychiatry 2000; 5: 105-109.
82. Slutske WS. Natural recovery and treatment-seeking in pathological gambling: results of two U.S. national surveys. Am J Psychiatry 2006; 163: 297-302.
83. Wojczynski MK, Tiwari HK. Definition of phenotype. Adv Genet 2008; 60: 75-105.